| Gene symbol | XIAP | Synonyms | API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | Type of gene | protein-coding | |
| Chromosome | X | Map location | Xq25 | dbXrefs | Entrez:331 MIM:300079 HGNC:HGNC:592 Ensembl:ENSG00000101966 AllianceGenome:HGNC:592 | |
| Gene perturbation-related omics dataset | PertOrg | |||||
| Description | X-linked inhibitor of apoptosis | |||||
| GTO ID | GTC1258 |
| Trial ID | NCT00363974 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | XIAP |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | AEG35156 |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | An Open-Label Phase I/II Study of XIAP Antisense AEG35156 Administered to Patients With Refractory/Relapsed AML in Combination With Chemotherapy |
| Year | 2006 |
| Country | Canada|United States |
| Company sponsor | Aegera Therapeutics |
| Other ID(s) | AEG35156-103|MDA 2005-0384|PMH 05-0452-C |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||